2017 Volume 37 Issue 3 Pages 455-460
Since the first report of their use in 1990, self─expandable metallic stents (SEMS) have been used to treat obstructive colorectal cancer. Numerous cases were treated with SEMS placement after SEMS treatment for obstructive colorectal cancer was included under the national insurance program in Japan. Since 2014, a total of 28 SEMS placements have been performed as “bridges to surgery” in our hospital, with technical and clinical success rates of 100% and 82%, respectively, and a complication rate of 7%. Twenty-five laparoscopic-assisted operations have also been performed. SEMS placement is considered a safe and feasible decompression method for the treatment of obstructive colorectal cancer.